2021 annual financial data
Amphastar Pharmaceuticals 2021 Operating cash flow margin
Amphastar Pharmaceuticals 2021 operating cash flow margin with verified reporte…
Direct answer
Operating cash flow margin was 22.38%.
Operating income was 69,887,000 USD and net income was 62,116,000 USD.
Operating cash flow was 97,994,000 USD.
Get free Amphastar Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 437,768,000 USD
- Operating income
- 69,887,000 USD
- Net income
- 62,116,000 USD
- Operating cash flow
- 97,994,000 USD